drugset / Trial / NCT00505063

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

NCT00505063 ↗

Phase 2 Completed 76 enrolled Memorial Sloan Kettering Cancer Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will look at your body's response to the new immunizations. We want to see how well they will protect you. Immunization is the same as vaccination. Our goal is to protect you as much as we can. We do not want you to have the measles, mumps, or whooping cough. We are doing the study because there is no standard way to re-immunize people after cancer treatments.

Timeline

Start
2007-07-10
Primary completion
2025-06-11
Completion
2025-06-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Boostrix Vaccine — —
Subject Gardasil Vaccine — —
Subject Hepatitis B Vaccine — —
Subject Hib Unknown — —
Subject Immunization Schedule patients > or = to 7 years and <11 years of age Unknown — —
Subject Measles, mumps, rubella, MMR Unknown — —
Subject Menactra Vaccine — —
Subject Pediarix Vaccine — —
Subject Prevnar 13 Vaccine — —
Subject Varivax Vaccine — —
Subject inactivated polio virus vaccine Unknown — —